LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR) President and CEO Steven A. Kriegsman and Chief Medical Officer Daniel Levitt, MD, Ph.D., shared their views on potential advantages of the Company and its oncology pipeline, and expanded on the commercialization strategy in an interview published in OncLive online.
